PRESTIGE CONSUMER HEALTHCARE
PBHNYSETrading Snapshot
- Day Range
- $46.26 β $47.60
- 52-Week Range
- $42.62 β $71.07
- Volume
- $3.22B
- Avg Volume
- $3.72B
- Shares Outstanding
- 47.4M
- Next Earnings
- Nov 3, 2026
Fundamentals Snapshot
- Annual Revenue
- $1.09B
- Last Q Revenue
- $266M
- P/E Ratio
- 13.1
- P/S Ratio
- 2.0x
- EPS (TTM)
- $3.62
- Dividend Yield
- 0.00%
- Dilution (1yr)
- β1.0%
Why Investors Own PBH
- βHigh-growth profile β revenue up +31.9% YoY with expanding US Equity exposure.
- βHealthy economics β 63% gross margin and 24% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
PRESTIGE CONSUMER HEALTHCARE
PBHAbout PRESTIGE CONSUMER HEALTHCARE
Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
PRESTIGE CONSUMER HEALTHCARE tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift PBH price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
PRESTIGE CONSUMER HEALTHCARE announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.